# Clinical Application of Methylene Blue for Treatment of Covid-19 Patients

> **NCT04370288** · PHASE1 · UNKNOWN · sponsor: **Mashhad University of Medical Sciences** · enrollment: 20 (estimated)

## Conditions studied

- Covid-19

## Interventions

- **DRUG:** MCN (Methylene blue, vitamin C, N-acetyl cysteine)

## Key facts

- **NCT ID:** NCT04370288
- **Lead sponsor:** Mashhad University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-19
- **Primary completion:** 2020-09-20
- **Final completion:** 2020-09-21
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04370288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04370288, "Clinical Application of Methylene Blue for Treatment of Covid-19 Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04370288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*